首页> 外国专利> SCD40L, PAPP-A AND PLACENTARY GROWTH FACTOR (PIGF) AS COMBINATIONS OF BIOCHEMICAL MARKERS IN CARDIOVASCULAR DISEASES.

SCD40L, PAPP-A AND PLACENTARY GROWTH FACTOR (PIGF) AS COMBINATIONS OF BIOCHEMICAL MARKERS IN CARDIOVASCULAR DISEASES.

机译:SCD40L,PAPP-A和胎盘生长因子(PIGF)作为心血管疾病中生物化学标记物的组合。

摘要

Procedure for the analysis of samples in relation to acute cardiovascular diseases, the procedure comprising the following steps: (a) making available a biological sample to be examined from a subject; (b) determine the concentration of the PlGF marker in the sample, (c) if necessary, determine the concentration of at least one other marker selected from soluble CD40 ligand (sCD40L), PAPP-A, troponin T (TnT), MPO, NT -proBNP, VEGF, BNP and other inflammatory markers, and (d) compare the result (s) obtained for the sample to be examined with reference values and / or reference sample values.
机译:用于分析与急性心血管疾病有关的样品的程序,该程序包括以下步骤:(a)提供要从受试者身上检查的生物样品; (b)确定样品中PlGF标记物的浓度,(c)必要时,确定至少一种选自可溶性CD40配体(sCD40L),PAPP-A,肌钙蛋白T(TnT),MPO的其他标记物的浓度, NT -proBNP,VEGF,BNP和其他炎性标记,并且(d)将要检查的样品获得的结果与参考值和/或参考样品值进行比较。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号